IP Library › Granted Patent US 11,592,371
Granted Patent B1
US 11,592,371 · App. 17/575,422 · Granted Feb 28, 2023

System and method for determining an immune activation state

Inventors: Henry Tat Kwong Tse (San Francisco, CA); Ajay M. Shah (San Francisco, CA); Lionel Guillou (San Francisco, CA); Alexander Malkin (San Francisco, CA); Anne E. Jensen (San Francisco, CA); Nicholas Martinez (San Francisco, CA); Carissa Colegrove (San Francisco, CA); Laura Voyen (San Francisco, CA)
Assignee: CytoVale Inc.
G01N1/34B01L3/502715B01L3/502761G01N1/4044G01N1/4077G01N15/1434G01N33/5005B01L2200/04B01L2200/0663B01L2300/0654G01N2015/008G01N2015/0069G01N2015/1006
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,592,371
App. No.
17/575,422
Granted
Feb 28, 2023
Kind
B1
Abstract

A method and/or system can include processing a blood sample of a patient by degrading red blood cells of the blood sample using a lysing solution, quenching the degradation of the red blood cells after a threshold lysing time, centrifuging and aspirating the quenched solution to remove degraded red blood cell debris and concentrate white blood cells of the blood sample, and suspending the concentrated white blood cells in a buffer solution; within a threshold transfer time, deforming white blood cells, of the suspended white blood cells, within a microfluidic chip; and determining a probability that the patient is in an immune activation state based on images of the white blood cells acquired while deforming the white blood cells.

Claims (19)

1. A method for diagnosing sepsis in a patient, comprising:

preheating a microfluidic chip to a target temperature;

mixing a blood sample from the patient with a formic acid solution to degrade red blood cells in the blood sample;

after a lysing time, quenching the blood sample and the formic acid solution with a quenching solution;

after a quenching time, washing the blood sample to remove lysed red blood cells from white blood cells of the blood sample;

resuspending the white blood cells in a buffer solution;

within a threshold time of resuspending the white blood cells, transferring the white blood cells in the buffer solution to the preheated microfluidic chip;

deforming the white blood cells within a deformation region of the microfluidic chip;

acquiring images of the white blood cells during deformation of the white blood cells; and

diagnosing sepsis in the patient based on features extracted from the images of the white blood cells, wherein the features comprise trajectory parameters, cell count, and leukocyte subpopulations.

2. The method of claim 1 , wherein the lysing time is about 10 seconds.

3. The method of claim 2 , wherein the quenching time is about 10 seconds.

4. The method of claim 1 , wherein washing the blood sample comprises washing the blood sample with about 10 ml of the buffer solution, wherein washing the blood sample comprises contemporaneously aspirating and centrifuging the blood sample.

5. The method of claim 1 , wherein the threshold time is at most about 5 minutes.

6. The method of claim 1 , wherein a volume of the white blood cells and the buffer solution is about 1 ml, wherein a temperature of the white blood cells and the buffer solution is about 25° C.

7. The method of claim 6 , further comprising:

determining a temperature of the white blood cells; and

preheating the buffer solution to a buffer temperature so that after resuspending the white blood cells in the buffer solution, a temperature of the white blood cells is about 25° C., wherein the buffer temperature depends on the temperature of the white blood cells.

8. The method of claim 6 , wherein the target temperature is about 25° C.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2022
From: TSE, HENRY TAT KWONG; SHAH, AJAY M.; GUILLOU, LIONEL; MALKIN, ALEXANDER; JENSEN, ANNE E.; MARTINEZ, NICHOLAS; COLEGROVE, CARISSA; VOYEN, LAURA
To: CYTOVALE INC.
Reel/Frame 058875/0251 →
Cited By (1)
US 12,478,966